---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-26-000107"
form_type: "8-K"
ticker: "VNRX"
cik: "0000093314"
company_name: "VOLITIONRX LTD"
filed_at: "2026-01-08T23:59:59+00:00"
generated_at: "2026-05-16T11:18:00.617542+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# VolitionRx secures $2.0M funding from Lind Global with convertible note and warrants

## Summary
- Gross proceeds $2M; issues $2.4M senior secured convertible note and 7,000,350 warrants at $0.5714/share.
- Note has 18 monthly payments of $133,333 beginning 6 months after issuance; no interest accrues.
- Lind may increase up to 2 monthly payments to $1M each on notice.
- This is additional to existing $7.5M note from May 2025 with Lind.
- Company must file resale registration statement within 30 days of closing.

## SEC filing metadata
- accession: 0001477932-26-000107
- form_type: 8-K
- ticker: VNRX
- cik: 0000093314
- company_name: VOLITIONRX LTD
- filed_at: 2026-01-08T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/93314/000147793226000107/0001477932-26-000107-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/93314/000147793226000107/vnrx_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-26-000107
- JSON: https://secwatch.observer/filing/0001477932-26-000107.json
- Plain text: https://secwatch.observer/filing/0001477932-26-000107.txt

## Key facts
- Equity Issuances
  VOLITIONRX LTD issued convertible note to Lind Global Asset Management XII LLC for principal amount of $2,400,000.
  - Security: convertible note
  - Purchaser: Lind Global Asset Management XII LLC
  - Consideration: principal amount of $2,400,000
  source text: we will receive $2,000,000 in funding from Lind in exchange for the issuance to Lind of a Senior Secured Convertible Promissory Note in the principal amount of $2,400,000
  evidence_url: https://www.sec.gov/Archives/edgar/data/93314/000147793226000107/0001477932-26-000107-index.htm
- Equity Issuances
  VOLITIONRX LTD issued 7,000,350 shares of warrant to Lind Global Asset Management XII LLC for $0.5714 per share.
  - Security: warrant
  - Shares: 7,000,350 shares
  - Purchaser: Lind Global Asset Management XII LLC
  - Consideration: $0.5714 per share
  source text: a Common Stock Purchase Warrant for the purchase of 7,000,350 shares of our common stock at a price of $0.5714 per share
  evidence_url: https://www.sec.gov/Archives/edgar/data/93314/000147793226000107/0001477932-26-000107-index.htm
- Material Agreements
  VOLITIONRX LTD amended Amended SPA with Lind Global Asset Management XII LLC valued at $2,000,000 (effective 2026-01-07).
  - Action: amendment
  - Agreement: equity purchase
  - Counterparty: Lind Global Asset Management XII LLC
  - Value: $2,000,000
  - Effective: 2026-01-07
  source text: On January 7, 2026, VolitionRx Limited (the “Company”) entered into an amended and restated securities purchase agreement (the “Amended SPA”) with Lind Global Asset Management XII LLC, a Delaware limited liability company (“Lind”). Under the Amended SPA, within ten business days of signing, and subject to the satisfaction of certain closing conditions, we will receive $2,000,000 in funding from Lind
  evidence_url: https://www.sec.gov/Archives/edgar/data/93314/000147793226000107/0001477932-26-000107-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.